July 17, 2024 11:21 AM EDTUpdated 01:06 PM
Pharma
FDA+

Big three PBMs will tes­ti­fy be­fore Con­gress next week, fol­low­ing FTC re­port

Drew Armstrong

Executive Editor

Phar­ma­cy ben­e­fit man­ag­er ex­ec­u­tives from Cigna, CVS Health and Unit­ed­Health Group are sched­uled to tes­ti­fy be­fore Con­gress on Ju­ly 23, giv­ing law­mak­ers a chance to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times